Todos los meses, Stanford Parkinson’s Community Outreach producirá una lista de seminarios web y reuniones virtuales en español relacionados con el Parkinson con oradores. Aquí está nuestra lista de Febrero de 2025.
… Full Story>
The U.S. Food and Drug Administration has approved a new technology that could offer more effective treatment for millions of people suffering from Parkinson’s disease. Approval of the new device is the result of Stanford-led research into adaptive deep brain stimulation. Helen Bronte-Stewart, MD, who headed the international study, explains how it could provide longer-lasting benefits of any current treatment.
… Full Story>
APDA’s Thriving Through Occupational Therapy series is returning with this helpful and informative episode that will focus on how PD can affect your memory and thinking and what you can do about it.
… Full Story>
For more than two decades, innovative program has focused on ‘what people with Parkinson’s can do, not what they can’t do.’
… Full Story>
Soania Mathur was diagnosed with Parkinson’s disease at the age of 27. Excerpts from this Washington Post article about her and young-onset Parkinson’s: “Mathur and health-care experts said that more awareness of early-onset Parkinson’s is needed, since some studies suggest that its incidence is increasing, going against the common belief that the rise in Parkinson’s cases is due to an aging population. … One study found that patients under 45 had a much longer latency from disease onset to diagnosis — over two years compared with nine months for late-onset patients. … Dystonia, a movement disorder characterized by sustained or intermittent muscle contractions, is more often seen in early-onset Parkinson’s disease, particularly after exercise. However, dementia, gait disturbances, gastrointestinal issues and loss of sense of smell are less frequent, less severe or delayed in younger individuals. Perhaps most intriguing is that the progression of the disease is much slower in early-onset patients.”
… Full Story>